CARDIFF ONCOLOGY, INC. (CRDF) Net income 2016–2025
CARDIFF ONCOLOGY, INC. (CRDF) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$45.9MFY2025 · since FY2016: -$39.2M → -$45.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$45.9M | -0.9% |
| FY2024 | -$45.4M | -9.6% |
| FY2023 | -$41.4M | -7.1% |
| FY2022 | -$38.7M | -36.8% |
| FY2021 | -$28.3M | -46.5% |
| FY2020 | -$19.3M | -17.6% |
| FY2019 | -$16.4M | +0.3% |
| FY2018 | -$16.5M | +33.9% |
| FY2017 | -$24.9M | +36.5% |
| FY2016 | -$39.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice